Delivery Order SPE2DB25D3012-SPE2DB25FWYTP
- Not listed
- The Defense Logistics Agency awarded a $9,133.25 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dupixent 300 mg/2 ml pen injections. This is a firm fixed price delivery order with an ultimate completion date of July 29, 2025, representing a short-duration pharmaceutical supply contract. The award carries no set-aside designation, indicating it was competitively awarded through open procurement processes. AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $25,186.62 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens (2 mL) under a firm fixed price contract type. The award was issued on August 1, 2025, with an ultimate completion date of August 4, 2025, and no set-aside designation was applied. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $32,001.89 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pens on July 29, 2025. This competitively awarded, firm fixed-price contract with an ultimate completion date of July 30, 2025 represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical. The pharmaceutical distributor will perform this...
- The Defense Logistics Agency awarded a delivery order valued at $49,427.15 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on July 23, 2025, with completion scheduled for July 24, 2025. This competitively awarded, firm fixed-price delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The pharmaceutical product will be...
- The Defense Logistics Agency awarded a $17,619.85 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency awarded a $12,356.56 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injections on July 29, 2025, with completion scheduled for July 30, 2025. This firm fixed-price contract, which received no set-aside designation, leverages AmerisourceBergen's position as a major pharmaceutical distributor supporting federal medical procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $8,436.25 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen medication on July 22, 2025, with an ultimate completion date of July 23, 2025. This is a firm fixed price, non-competitive delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dupixent 300 mg/2 mL pens with a ceiling value of $7,398.80. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026....
- The Defense Logistics Agency awarded a $35,339.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens (2 mL formulation) with an ultimate completion date of July 24, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $15,942.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Dupixent 300 mg/2 mL pens. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The delivery location is AmerisourceBergen's corporate office in Conshohocken,...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWYTPDelivery Order
The Defense Logistics Agency awarded a $59,618.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pens on July 22, 2025, with completion targeted for July 23, 2025. This non-set-aside award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location and supply the biologic medication to support federal military healthcare requirements. This delivery order exemplifies AmerisourceBergen's established role as a critical pharmaceutical vendor within the Defense Logistics Agency's medical supply chain. As a major healthcare solutions provider, the company maintains a comprehensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The firm fixed-price structure and competitive award mechanism reflect AmerisourceBergen's demonstrated capability to meet federal procurement standards, consistent with its broader contract performance history supplying medications and medical commodities to military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $59.6k | 7/22/25 |